Novo Nordisk A/S Completes Divestment of ZymoGenetics, Inc.

BAGSVAERD, DENMARK--(Marketwire - October 08, 2010) -


[HUG#1450252]

Company Announcement no 56 2010: http://hugin.info/2013/R/1450252/391728.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.


Source: Novo Nordisk A/S via Thomson Reuters ONE


Further information:

Media:

Mike Rulis
Tel: (+45) 4442 3573
Email Contact

In North America:
Lori Moore
Tel: (+1) 609 919 7991
Email Contact

Investors:

Klaus Bülow Davidsen
Tel: (+45) 4442 3176
Email Contact

Kasper Roseeuw Poulsen
Tel: (+45) 4442 4471
Email Contact

Jannick Lindegaard
Tel: (+45) 4442 4765
Email Contact

In North America
Hans Rommer
Tel: (+1) 609 919 7937
Email Contact

MORE ON THIS TOPIC